DDG2026
DDG: Therapy_Type_2.pdf pdf
Zusammenfassung
Therapy of Type 2 Diabetes
Authors
Rüdiger Landgraf1, Jens Aberle2, Andreas L. Birkenfeld3, Baptist Gallwitz4, Monika Kellerer5, Harald Klein6,
Dirk Müller-Wieland7, Michael A. Nauck8, Tobias Wiesner9, Erhard Siegel10
Affiliations
1 German Diabetes Foundation, Munich, Germany
2 Division of Endocrinology and Diabetology, University
Obesity Centre Hamburg, University Hospital HamburgEppendorf, Germany
3 German Centre for Diabetes Research (DZD e. V.),
Neuherberg, Germany
4 Department of Internal
Kerninformationen
ernal Medicine I, University Hospital
RWTH, Aachen, Germany
8 Diabetes Centre Bochum-Hattingen, St.-Josef-Hospital,
Ruhr-University, Bochum, Germany
9 MVZ Metabolic Medicine Leipzig, Leipzig, Germany
10 Department of Internal Medicine – Gastroenterology,
Diabetology/Endocrinology and Nutritional Med...
es” [1]. The modifications in therapy and their justifications
made in the present Clinical Practice Guidelines were updated on
the basis of new randomized controlled trials (RCTs) and meta-analyses.
In order to improve the work with the extensive practice guideline in practice, the authors have dec...
iation: Clinical Practice Guidelines
This is a translation of the DDG clinical practice guideline
published in Diabetologie 2021; 16 (Suppl 2): S168–S206.
DOI 10.1055/a-1394-2313
Correspondence
Prof. Dr. med. Rüdiger Landgraf
German Diabetes Foundation
Germeringer Straße 101⁄2
82131 Gauting
Germany
...
Fragen zu diesem Thema?
ClariMed durchsucht alle Leitlinien mit KI und liefert quellenbasierte Antworten in Sekunden.
Jetzt auf ClariMed suchenVerwandte Leitlinien
Cochrane2019
Cochrane Review: Metformin and second- or third-generation sulphonylurea combination therapy for adults with type 2 diabetes mellitus
International Diabetes Federation2025
IDF Global Clinical Practice Recommendations for Managing Type 2 Diabetes 2025
Cochrane2024
Cochrane Review: Sodium-glucose co-transporter protein 2 (SGLT2) inhibitors for people with chronic kidney disease and diabetes
CCS2023
CCS 2023 Cardiorenal Risk Reduction Guidelines: GLP-1 RA and SGLT2i
Cochrane2025
Cochrane Review: Glucagon-like peptide 1 (GLP-1) receptor agonists for people with chronic kidney disease and diabetes
Cochrane2020
Cochrane Review: Metformin monotherapy for adults with type 2 diabetes mellitus
KDIGO2022
KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease
DDG2025